In a study of CSF NfL levels in a longitudinal multicenter cohort, patients with PSP and MSA had higher levels of CSF NfL than the PD group, whereas the control group had lower levels of NfL (Mollenhauer et al., 2020). The gene discussed is NEFL; the disease is supranuclear palsy, progressive, 1.